DaVita healthCare Partners Inc. Analyst Rating Update - News Watch International Print

DaVita healthCare Partners Inc. (NYSE:DVA) has received a hold rating for the short term, according to the latest rank of 3 from research firm, Zacks. The company received an average rating of 1.8 from 10 analysts. 6 have rated it as a strong buy. 4 analysts have rated the company at hold.

Many analysts have commented on the company rating. Baird upgrades its view on DaVita healthCare Partners Inc. (NYSE:DVA) according to the research report released by the firm to its investors. The shares have now been rated Outperform by the stock experts at the ratings house. Earlier, the shares had a rating of Neutral. Baird raises the price target from $75 per share to $95 per share on DaVita healthCare Partners Inc.. The rating by the firm was issued on April 27, 2015. DaVita healthCare Partners Inc. (NYSE:DVA) shares are expected to touch $89.67 in the short term. This short term price target has been shared by 6 analysts. However, the standard deviation of short term price estimate has been valued at 5.75. The target price could hit $96 on the higher end and $83 on the lower end. Mondays trading session turned out to be a no-profit no-loss event for DaVita healthCare Partners Inc. (NYSE:DVA). The opening trade occurred at $79.95 and the highest and the lowest points of the day were $80.3 and $79.6101 respectively. The final trade was registered at $80.28 and the volume by the end of the day had touched 874,348 shares. The 52-week high of the stock is $85.17 and the 52-week low is $71.43. According to the current valuation, the market cap of the company is $17,300 million and the total number of shares available in public circulation is 215,500,000. DaVita HealthCare Partners Inc. has dropped 0.95% in the last five trading days, however, the shares have posted positive gains of 0.39% in the last 4 weeks. DaVita HealthCare Partners Inc. has dropped 2.93% during the last 3-month period . Year-to-Date the stock performance stands at 5.99%. On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, The Securities and Exchange Commission has divulged that Jiganti Jeanine Marie, officer (Chief Compliance Officer) of Davita Healthcare Partners Inc., had unloaded 1,311 shares at an average price of $81.37 in a transaction dated on August 10, 2015. The total value of the transaction was worth $106,676. DaVita HealthCare Partners Inc., formerly DaVita Inc., is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In July 2013, DaVita, a division of DaVita HealthCare Partners Inc announced the acquisition of the dialysis operations of Malaysias Caring Dialysis Centre Group (CDC Group) by DVA (Malaysia) Sdn Bhd. NO COMMENTS LEAVE A REPLY Cancel reply